Exhibitor Spotlight
INDConf LONDON 2025 will host a select group of exhibitors showcasing innovation, support, and services at the forefront of neurotransmitter disorder care and research.
With a maximum of 10 curated exhibitors, delegates will enjoy a more personal and meaningful opportunity to:
- Explore cutting-edge clinical tools, diagnostics, and therapeutic solutions
- Connect with organisations involved in gene therapy, neurometabolic medicine, and patient care
- Access trusted resources from both industry leaders and patient advocacy groups
Exhibitors include a number of our valued sponsors and partners, offering further insight into the real-world impact of their work.
The exhibition area will be open throughout the conference, with dedicated networking time included in the programme.
Whether you're a clinician, researcher, or advocate, we invite you to take full advantage of this focused space for discovery, conversation, and collaboration.
Exhibitor Spotlight...
Meet PTC Therapeutics
We’re pleased to welcome PTC Therapeutics as an exhibitor at INDConf LONDON 2025.
Known for pioneering work in rare disease therapeutics, including the first gene therapy for AADC deficiency, PTC brings deep expertise in translating science into meaningful outcomes.
Visit their stand to learn more about their clinical programs, research partnerships, and ongoing commitment to innovation in neurotransmitter disorders.
Meet Vitaflo International
We’re delighted to welcome Vitaflo to the INDConf LONDON 2025 exhibition hall.
A global leader in specialised medical nutrition, Vitaflo brings decades of expertise in developing innovative nutritional solutions for inherited metabolic disorders and complex neurological conditions.
At their exhibitor stand, delegates can explore practical, patient-centred products and speak with the team about how tailored nutrition is supporting treatment outcomes across the rare disease spectrum.
Don’t miss the chance to connect with Vitaflo and discover how nutrition and care go hand in hand.
Meet the UCL Neurometabolic Unit
We’re proud to feature the UCLH Neurometabolic Unit as an exhibitor at INDConf LONDON 2025.
As a UK leader in diagnostic testing and translational research for neurotransmitter and metabolic disorders, the Unit offers vital insights into clinical diagnostics, assay development, and collaborative research.
Visit their stand to explore how laboratory innovation is advancing rare disease care from Queen Square to the clinic.
Meet the Guildford Street Laboratories
We’re excited to welcome Guildford Street Laboratories (GSL) as a featured exhibitor at INDConf LONDON 2025.
A UCL spin-out founded in 2023, GSL leverages AI-enhanced mass spectrometry to deliver highly sensitive and precise protein, lipid, and metabolite biomarker assays across the entire clinical journey—from early diagnosis to trial monitoring and personalised medicine.
Their recent partnership with UCLH’s Neurometabolic Unit marks a UK-first diagnostic collaboration, using advanced mass spec and machine learning to create next-generation tests for Parkinson’s, mitochondrial, and neurotransmitter disorders.
Visit GSL’s stand to explore how their innovation is transforming rare disease diagnostics and accelerating bench-to-bedside translation.
Exhibitor
Coming Soon...
Exhibitor
Coming Soon...
